SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...

That’s according to a clinical trial conducted in 11 countries — the first of its kind to show that one of the wave of ...

Popular GLP-1 drugs are already known to have many benefits, but scientists continue to explore what else they — and their ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

Namodenoson is an oral drug with a proven favorable safety profileRAMAT GAN, Israel, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd.

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

Can-Fite BioPharma (CANF) has released an update. Can-Fite BioPharma Ltd. has received a patent allowance in Australia for ...

Ilant Health, a leading provider of value-based obesity and cardiometabolic health solutions, today announced that Galway Holdings, a prominent financial services firm, will provide Ilant's ...